Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.
HNHA
Cayman Chemical Item Number 13295
Histone Deacetylase Inhibitor VI
(CAS 926908-04-5)
HNHA is a cell-permeable inhibitor of histone deacetylase (HDAC) activity (IC50 = 100 nM).1 In human fibrosarcoma HT1080 cells, it induces histone hyperacetylation and p21 transcription with concomitant inhibition of cell cycle progression (IC50 ~ 7.5 μM).1 HNHA is at least as effective as SAHA in inhibiting tumor growth in a murine xenograph model in vivo.1 HNHA also blocks the growth of human umbilical vein endothelial cells (HUVECs) and prevents tube formation and migration of HUVECs in response to vascular endothelial growth factor (VEGF). It also blocks retinal neovascularization and choroidal angiogenesis in mice.2
1
Kim, D.H., Lee, J., Kim, K.N., et al. Anti-tumor activity of N-hydroxy-7-(2-naphthylthio) heptanomide, a novel histone deacetylase inhibitor. Biochem Biophys Res Commun356233-238(2007).
2
Kim, J.H., Kim, J.H., Oh, M., et al. N-hydroxy-7-(2-naphthylthio) heptanomide inhibits retinal and choroidal angiogenesis. Mol Pharm6(2)513-519(2009).
Synonyms
Histone Deacetylase Inhibitor VI
Formal Name
N-hydroxy-7-(2-naphthalenylthio)-heptanamide
CAS Number
926908-04-5
Molecular Formula
C17H21NO2S
Formula Weight
303.4
Formulation
A crystalline solid
Purity
≥98%
Stability
2 years
Storage
-20°C
Shipping
Room temperature
in continental US; may vary elsewhere
SMILES
Copy SMILES to clipboard
c1ccc2c(c1)cc(cc2)SCCCCCCC(NO)=O
Background Reading
Kim, J.H., Kim, J.H., Oh, M., et al. N-hydroxy-7-(2-naphthylthio) heptanomide inhibits retinal and choroidal angiogenesis. Mol Pharm6(2)513-519(2009).
Kim, D.H., Lee, J., Kim, K.N., et al. Anti-tumor activity of N-hydroxy-7-(2-naphthylthio) heptanomide, a novel histone deacetylase inhibitor. Biochem Biophys Res Commun356233-238(2007).
HNHA is available in the following screening
library: